New group of xylene linker-containing acetylcholinesterase reactivators as antidotes against the nerve agent cyclosarin

References

• Bajgar J. Organophosphates/nerve agent poisoning: Mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 2004; 38: 151–216
   PubMed Web of Science ®Google Scholar
• Robinson PJ. The problem of chemical and biological warfare agents. Almqvist and Wiksell, SIPRI 1973; Vol 2., CB weapons today
   Google Scholar
• Black RM, Clarke RJ, Read RW, Reid MT. Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to the analysis of chemical warfare samples, found to contain residues of the nerve agent sarin, sulphur mustard and their degradation products. J Chromatogr A 1994; 662: 301–321
   PubMed Web of Science ®Google Scholar
• Bolz F, Dudonis KJ, Schulz DP. The counterterrorism Handbook – Tactics, Procedures, and Techniques. CRC Press. 2002
   Google Scholar
• Marrs TC. Organophosphate poisoning. Pharmacol Ther 1993; 58: 51–66
   PubMed Web of Science ®Google Scholar
• Taylor P. The Pharmacological Basis of Therapeutics. McGraw Hill. 1996
   Google Scholar
• Kuca K, Jun D, Musilek K. Structural requirements of acetylcholinesterase reactivators. Mini Rev Med Chem 2006; 6: 269–277
   PubMed Web of Science ®Google Scholar
• Kim TH, Kuca K, Jun D, Jung YS. Design and synthesis of new bis-pyridinium oximes as cyclosarin-inhibited acetylcholinesterase reactivators. Bioorg Med Chem Lett 2005; 15: 2914–2917
   PubMed Web of Science ®Google Scholar
• Yang GY, Yoon JH, Seong CM, Park NS, Jung YS. Synthesis of bis-pyridinium oxime antidotes using bis(methylsulfonoxymethyl) ether for organophosphate nerve agents. Bull Korean Chem Soc 2003; 24: 1368–1370
   Web of Science ®Google Scholar
• Picha J, Kuca K, Kivala M, Kohout M, Cabal J, Liska F. New group of monoquaternary reactivators of the acetylcholinesterase inhibited by nerve agents. J Enz Inhib Med Chem 2005; 20: 233–237
   PubMed Web of Science ®Google Scholar
• Musilek K, Kuca K, Jun D, Dohnal V, Dolezal M. Synthesis of the novel series of bispyridinium compounds bearing xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. J Enz Inhib Med Chem 2005; 20: 409–415
   PubMed Web of Science ®Google Scholar
• Krejcova G, Kuca K, Sevelova L. Cyclosarin - current position of an organophosphate nerve agent. Def Sci J 2005; 55: 105–115
   Web of Science ®Google Scholar
• Petroianu GA, Hasan MY, Nurulain SM, Arafat K, Shafiullah M, Naseer O. Protective agents in acute high-dose organophosphate exposure: Comparison of ranitidine with pralidoxime in rats. J Appl Toxicol 2005; 25: 68–73
   PubMed Web of Science ®Google Scholar
• Palecek J, Cirkva V, Relich S, Slavetinska L, Kuca K, Jun D. Assignment of organophosphorus-inhibited acetylcholinesterase reactivators structures on the basis of nuclear magnetic resonance spectra. Zprav Voj Farm 2005; 15: 14–25, (In Czech)
   Google Scholar
• Kuca K, Cabal J. Evaluation of newly synthesized reactivators of the brain cholinesterase inhibited by sarin-nerve agent. Toxicol Mech Meth 2005; 15: 247–252
   PubMed Web of Science ®Google Scholar
• Kuca K, Kassa J. A comparison of the ability of a new byispyridinium oxime – 1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J Enz Inhib Med Chem 2003; 18: 529–535
   PubMed Web of Science ®Google Scholar
• Petroianu GA, Arafat K, Kuca K, Kassa J. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibitied by paraoxon. J Appl Toxicol 2006; 26: 64–71
   PubMed Web of Science ®Google Scholar
• Calic M, Vrdoljak AL, Radic B, Jelic D, Jun D, Kuca K, Kovarik Z. In vitro and in vivo evaluation of pyridinium oximes: Mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Toxicology 2006, 219:85–96
   Google Scholar
• Worek F, Reiter G, Eyer P, Szinicz L. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates. Arch Toxicol 2002; 76: 523–529
   PubMed Web of Science ®Google Scholar
• Luo C, Leader H, Radic Z, Maxwell DM, Taylor P, Doctor BP, Saxena A. Two possible orientations of the HI-6 molecule in the reactivation of organophosphate-inhibited acetylcholinesterase. Biochem Pharmacol 2003; 66: 387–392
   PubMed Web of Science ®Google Scholar
• Worek F, Widmann R, Knopff O, Szinicz L. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLo 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol 1998; 72: 237–243
   PubMed Web of Science ®Google Scholar
• Clement JG, Erhardt N. In vitro oxime-induced reactivation of various molecular forms of soman-inhibited acetylcholinesterase in striated muscle from rat, monkey and human. Arch Toxicol 1994; 68: 648–655
   PubMed Web of Science ®Google Scholar
• Cabal J, Kuca K, Kassa J. Specification of the structure of oximes able to reactivate tabun inhibited acetylcholinesterase. Bas Clin Pharmacol Toxicol 2004; 95: 81–86
   PubMed Web of Science ®Google Scholar
• Sakurada K, Matsubara K, Shimizu K, Shiono H, Seto Y, Tsuge K, Yoshino M, Sakai I, Mukoyama H, Takatori T. Pralidoxime iodide (2-PAM) penetrates across the blood-brain barrier. Neurochem Res 2003; 28: 1401–1407
   PubMed Web of Science ®Google Scholar
• Kuca K, Patocka J. Reactivation of cyclosarin-inhibited rat brain acetylcholinesterase by pyridinium-oximes. J Enz Inhib Med Chem 2004; 19: 39–43
   PubMed Web of Science ®Google Scholar
• Kuca K, Cabal J, Jun D, Kassa J, Bartosova L, Kunesova G, Dohnal V. Development of new acetylcholinesterase reactivators – antidotes used for treatment of nerve agent poisonings. Biomed Papers 2005; 149: 429–431
   PubMedGoogle Scholar
• Bartosova L, Kuca K, Jun D, Kunesova G. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning – in vitro and in vivo testing. Inter J Toxicol 2005; 24: 399–402
   PubMed Web of Science ®Google Scholar
• Sevelova L, Kuca K, Krejcova G. Antidotal treatment of GF-agent intoxication in mice with new bispyridinium oximes. Toxicology 2005; 207: 1–6
   PubMed Web of Science ®Google Scholar
• Krejcova-Kunesova G, Bartosova L, Kuca K. Signs of cyclosarin-induced neurotoxicity and its pharmacological treatment with quaternary pyridinium-oximes reactivators. Toxicology 2005; 216: 32–40
   PubMed Web of Science ®Google Scholar